Medical Finalist - NETrolyze: A Novel Immunotherapy for Triple-Negative Breast Cancer

TBMG-51930

11/01/2024

Abstract
Content

Sam Currier and Priyan Weerrappuli University of Michigan West Bloomfield, MI

Meta TagsDetails
Citation
"Medical Finalist - NETrolyze: A Novel Immunotherapy for Triple-Negative Breast Cancer," Mobility Engineering, November 1, 2024.
Additional Details
Publisher
Published
Nov 1, 2024
Product Code
TBMG-51930
Content Type
Magazine Article
Language
English